Century Therapeutics, Inc. - IPSC
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | See Remarks | S | D | 2,584.0 | 2.232 | 5,767.49 | 512,319.0 | View | |
| Jun 15, 2026 | SVP Finance & Operations | S | D | 1,654.0 | 2.232 | 3,691.73 | 505,094.0 | View | |
| Jun 15, 2026 | President and CEO | F | D | 13,849.0 | 2.24 | 31,021.76 | 3,665,474.0 | View | |
| Jun 15, 2026 | Chief Scientific Officer | F | D | 358.0 | 2.24 | 801.92 | 1,175,322.0 | View | |
| Jun 12, 2026 | — | A | A | 74,000.0 | 0.0 | 0.0 | 74,000.0 | View | |
| Jun 12, 2026 | — | A | A | 74,000.0 | 0.0 | 0.0 | 74,000.0 | View | |
| Jun 12, 2026 | — | A | A | 74,000.0 | 0.0 | 0.0 | 74,000.0 | View | |
| Jun 12, 2026 | — | A | A | 74,000.0 | 0.0 | 0.0 | 74,000.0 | View | |
| Jun 12, 2026 | — | A | A | 74,000.0 | 0.0 | 0.0 | 74,000.0 | View | |
| Jun 09, 2026 | See Remarks | S | D | 524.0 | 2.111 | 1,106.16 | 514,903.0 | View | |
| Jun 09, 2026 | SVP Finance & Operations | S | D | 249.0 | 2.111 | 525.64 | 506,748.0 | View | |
| Jun 09, 2026 | President and CEO | F | D | 463.0 | 2.13 | 986.19 | 3,679,323.0 | View | |
| May 19, 2026 | President and CEO | F | D | 31,172.0 | 2.34 | 72,942.48 | 3,679,786.0 | View | |
| May 06, 2026 | SVP Finance & Operations | S | D | 264.0 | 2.341 | 618.02 | 506,997.0 | View | |
| Apr 10, 2026 | — | A | A | 88,000.0 | 0.0 | 0.0 | 88,000.0 | View | |
| Apr 03, 2026 | Chief Scientific Officer | F | D | 1,365.0 | 2.19 | 2,989.35 | 1,175,680.0 | View | |
| Mar 16, 2026 | SVP Finance & Operations | S | D | 7,043.0 | 2.549 | 17,952.61 | 507,261.0 | View | |
| Mar 16, 2026 | See Remarks | S | D | 10,076.0 | 2.549 | 25,683.72 | 515,427.0 | View | |
| Mar 13, 2026 | President and CEO | F | D | 55,397.0 | 2.73 | 151,233.81 | 3,710,958.0 | View | |
| Mar 13, 2026 | Chief Scientific Officer | F | D | 1,431.0 | 2.73 | 3,906.63 | 1,177,045.0 | View | |
| Mar 11, 2026 | See Remarks | S | D | 479.0 | 2.536 | 1,214.74 | 525,503.0 | View | |
| Mar 11, 2026 | SVP Finance & Operations | S | D | 247.0 | 2.536 | 626.39 | 514,304.0 | View | |
| Mar 10, 2026 | President and CEO | F | D | 463.0 | 2.56 | 1,185.28 | 3,766,355.0 | View | |
| Feb 18, 2026 | President and CEO | F | D | 31,172.0 | 1.75 | 54,551.0 | 3,766,818.0 | View | |
| Feb 05, 2026 | SVP Finance & Operations | S | D | 323.0 | 1.822 | 588.51 | 514,551.0 | View | |
| Feb 04, 2026 | SVP Finance & Operations | A | A | 225,000.0 | 0.0 | 0.0 | 225,000.0 | View | |
| Feb 04, 2026 | SVP Finance & Operations | A | A | 110,000.0 | 0.0 | 0.0 | 514,874.0 | View | |
| Feb 04, 2026 | Chief Scientific Officer | A | A | 265,000.0 | 0.0 | 0.0 | 265,000.0 | View | |
| Feb 04, 2026 | Chief Scientific Officer | A | A | 135,000.0 | 0.0 | 0.0 | 1,178,476.0 | View | |
| Feb 04, 2026 | See Remarks | A | A | 265,000.0 | 0.0 | 0.0 | 265,000.0 | View | |
| Feb 04, 2026 | See Remarks | A | A | 135,000.0 | 0.0 | 0.0 | 525,982.0 | View | |
| Feb 04, 2026 | President and CEO | A | A | 945,000.0 | 0.0 | 0.0 | 945,000.0 | View | |
| Feb 04, 2026 | President and CEO | A | A | 475,000.0 | 0.0 | 0.0 | 3,797,990.0 | View |